期刊文献+

人参皂苷糖苷水解酶高产菌株CGMCC No.4316发酵工艺 被引量:2

The fermentation technology for Absidia glauca CGMCC No. 4316 producing glycoside hydrolase of ginsenoside
下载PDF
导出
摘要 灰绿犁头霉Absidia glauca CGMCC No.4316具有将人参二醇类皂苷Rb1专一转化成Rd的活性。该文采用TLC法,在单因子试验基础上,应用响应面分析,以人参皂苷糖苷酶活力为响应值,建立回归模型,对培养基等各影响因子进行优化。试验结果表明:以麦麸皮20.47 g/L为碳源,蛋白胨9.74 g/L为氮源,初始pH 6.0,瓶装量45 mL/250 mL,摇瓶转数180 r/min,投料量10%,30℃发酵72 h,其酶活力达到92.78 U/mL。 The patent strain CGMCC No. 4316 of Absidia glauca is capable of converting ginsenoside RbI into Rd specifically. The research was conducted to optimize the factors of fermentation broth and related conditions by TCL assay based on single factor test associated with response surface methodology, and the activity of ginsenoside-glycosi- dase was used as response value to establish regression model. The results showed that under the optimal conditions of wheat bran 20.47 g/L as carbon source, peptone 9.74 g/L as nitrogen source, initial pH 6.0, culture medium vol- ume 45 mL/250 mL, shake flask revolutions of 180 r/min, inventory 10.00% , culture temperature 30 ℃ for 72 h fermentation, the enzyme activity reached 92.78 U/mL.
出处 《食品与发酵工业》 CAS CSCD 北大核心 2014年第6期85-90,共6页 Food and Fermentation Industries
基金 国家自然科学基金项(编号30770009) 中央高校基本科研业务费项目资助(DC12010)
关键词 人参皂苷糖苷酶 发酵优化 CGMCC No.4316菌株 响应面 Ginsenoside-glycosidase, fermentation optimization, Absidia glauca CGMCC No. 4316 strain, responsesill"fat e
  • 相关文献

参考文献18

二级参考文献43

共引文献170

同被引文献16

  • 1林东海,侯茂奇,陈继永,李金明,刘珂.人参皂苷Rg_3与羟丙基-β-环糊精包合作用的研究[J].中草药,2006,37(9):1328-1331. 被引量:7
  • 2YANG W Z,HU Y,WU W Y,et al. Saponins in the genus Panax L. (Araliaceae) : A systematic review of their chemi- cal diversity [ J ]. Phytochemistry (Elsevier) , 2014,106 : 7 - 24.
  • 3Lee C H,Kim J H. A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases [ J ]. Journal of Ginseng Research ,2014,38 ( 3 ) : 161 - 166.
  • 4WEN X, ZHANG H D, ZHAO L,et al. Ginsenoside Rh2 differentially mediates microrna expression to prevent che-moresistance of breast cancer [ J ]. Asian Pacific Journal of Cancer Prevention : APJCP ,2015,16 ( 3 ) : 1 105 - 1 109.
  • 5YANG X D, YANG Y Y, Ouuang D S,et al. A review of biotransformation and pharmacology of ginsenoside com- pound K[ J]. Fitoterapia ,2015,100:208 - 220.
  • 6WANG R F, ZHENG M M, CAO Y D,et al. Enzymatic transformation of vina-ginsenoside R7 to rare notoginsen- oside ST-4 using a new recombinant glycoside hydrolase from Herpetosiphon aurantiacus [ J ] . Applied Microbiology and Biotechnology ,2015,99 ( 8 ) :3 433 - 3 442.
  • 7QUAN L H, JIN Y,WANG C, et al. Enzymatic transforma- tion of the major ginsenoside Rb2 to minor compound Y and compound K by a ginsenoside-hydrolyzing /3-glycosidase from Mierohacterium esteraromatieum[ J ]. Journal of Indus- trial Microbiology & Biotechnology ,2012,39 ( 10 ) : 1 557 - 1 562.
  • 8Ansari S A, Satar R. Recombinant ,8-galactosidases-Past, present and future : A mini review [ J ]. Journal of Molecu- lar Catalysis B : Enzymatic ,2012,81 : 1 - 6.
  • 9Park A R, Oh D K. Galacto-oligosaccharide production u- sing microbial ~8-galactosidase: current state and perspec- tives [ J ]. Applied Microbiology and Biotechnology, 2010, 85(5):1 279-1 286.
  • 10Higuchi T, Connors K A. Phase-solubility techniques [ J ] Advance Analysis Chemistry Instrumentation, 1965, 4 117 -212.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部